ClinicalTrials.govpublic full text
Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
diabetic nephropathy, diabetic retinopathy, proteomics, diabetes, chronic kidney disease, mineralocorticoid receptor antagonists, spironolactone, microalbuminuria, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803436
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.